PubMed ID,Title,Publication Date,Non-academic Author,Company Affiliation,Corresponding Author Email
40634174,"Corrigendum to ""AGREE-II appraisal of lung cancer management clinical practice guidelines by the OPT...",2025 Jul 8,Pfizer Pharma,"Pfizer Pharma GmbH, Berlin, Germany.",N/A
40633934,Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.,2025 Jul 8,String Technologies,"Research and Development, NanoString Technologies Inc, Seattle, Washington, USA.",N/A
40631776,The prognostic impact of human epidermal growth factor receptor 2 status in metastatic colorectal ca...,2025 Dec,Pfizer Inc,"Pfizer Inc, South San Francisco, CA, USA.",N/A
40631456,Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN...,2025 Aug,Clinical Pharmacy,"Department of Clinical Pharmacy, Hopital Necker-Enfants Malades, AP-HP, Paris, France.",N/A
